ALPS ETF TR - MED BREAKTHGH (SBIO)

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,596,572
Share change
-544,380
Total reported value
$44,998,968
Put/Call ratio
0%
Price per share
$28.14
Number of holders
47
Value change
-$17,931,866
Number of buys
20
Number of sells
32

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2018

As of 31 Dec 2018, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,596,572 shares. The largest 10 holders included UBS Group AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, Bouchey Financial Group Ltd, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RAYMOND JAMES & ASSOCIATES, NTV Asset Management LLC, and JANE STREET GROUP, LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.